The Multifaceted Roles of Eukaryotic Elongation Factor 1‐Alpha‐2 in Neurodevelopmental and Neurodegenerative Disorders
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in The Scientific World Journal
- Vol. 2026 (1) , e4373377
Abstract
Eukaryotic elongation factor 1‐alpha‐2 (eEF1A2) is a neuron‐ and muscle‐specific translation elongation factor isoform that supports high‐demand proteostasis in terminally differentiated cells. Beyond its canonical role in translation elongation, eEF1A2 participates in noncanonical processes linked to actin cytoskeleton regulation, compartmentalized/local translation, and stress–response signaling. A central challenge in the field is that the strength and type of evidence implicating eEF1A2 differ substantially across disease classes. In neurodevelopmental disorders, heterozygous de novo pathogenic variants in EEF1A2 provide strong causal human genetic evidence for developmental and epileptic encephalopathies and related phenotypes, supported by functional studies showing reduced de novo protein synthesis/elongation and altered actin bundling in common patient‐associated variants. In contrast, in neurodegenerative paradigms (e.g., toxin‐based Parkinson′s disease models and ischemia‐reperfusion injury), eEF1A2 is primarily implicated as a contributory node within oxidative stress, autophagy/mitophagy, and inflammatory signaling pathways, largely based on cellular and animal model evidence rather than Mendelian causality. This review adopts an evidence‐based framework and organizes findings around a unified mechanistic model connecting canonical elongation and noncanonical cytoskeleton/stress/autophagy functions to neuronal phenotypes. Collectively, current evidence supports a causal role for eEF1A2 in neurodevelopmental disorders but only a contributory role in neurodegenerative conditions.Keywords
This publication has 58 references indexed in Scilit:
- Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and MisassembledThe Journal of Neuroscience, 2006
- Progressive Loss of Motor Neuron Function in Wasted Mice: Effects of a Spontaneous Null Mutation in the Gene for the eEF1A2 Translation FactorJournal of Neuropathology & Experimental Neurology, 2005
- Immuno-characterization of the switch of peptide elongation factors eEF1A-1/EF-1α and eEF1A-2/S1 in the central nervous system during mouse developmentDevelopmental Brain Research, 2004
- Not just for housekeeping: protein initiation and elongation factors in cell growth and tumorigenesisJournal of Molecular Medicine, 2003
- Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavageNucleic Acids Research, 2002
- Novel Interaction between the M4 Muscarinic Acetylcholine Receptor and Elongation Factor 1A2Journal of Biological Chemistry, 2002
- The Human Elongation Factor 1 A-2 Gene (EEF1A2): Complete Sequence and Characterization of Gene Structure and Promoter ActivityGenomics, 2000
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2Nature Genetics, 1999
- The lethal mutation of the mouse wasted ( wst ) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1α, encoded by the Eef1a2 geneProceedings of the National Academy of Sciences, 1998
- Assignment of Human Elongation Factor 1α Genes:EEF1AMaps to Chromosome 6q14 andEEF1A2to 20q13.3Genomics, 1996